1. Food-Derived β-Carboline Alkaloids Ameliorate Lipid Droplet Accumulation in Human Hepatocytes
   Dya Fita Dibwe et al, 2022, Pharmaceuticals CrossRef
2. Natural product puerarin activates Akt and ameliorates glucose and lipid metabolism dysfunction in hepatic cells
   Yunbing Shen et al, 2019, Journal of Functional Foods CrossRef
3. Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages
   Cong-hui Li et al, 2017, European Journal of Pharmacology CrossRef
4. The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism
   Sha Li et al, 2020, Frontiers in Pharmacology CrossRef
5. Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives
   Xianmin Dai et al, 2021, Chinese Medicine CrossRef
6. Effects of Apple Polyphenols and Taurine on Growth Performance, Tissue Morphology, and Lipid and Glucose Metabolism in Rice Field Eel (Monopterus albus) Fed High Oxidized Fish Oil
   Shanshan Wu et al, 2023, Aquaculture Nutrition CrossRef
7. Effect of the Fermentation Broth of the Mixture of Pueraria lobata, Lonicera japonica, and Crataegus pinnatifida by Lactobacillus rhamnosus 217-1 on Liver Health and Intestinal Flora in Mice With Alcoholic Liver Disease Induced by Liquor
   Ting Wang et al, 2021, Frontiers in Microbiology CrossRef
8. Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease
   Jiashu Pan et al, 2022, Biomedicine & Pharmacotherapy CrossRef
9. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway
   Jiaxin Zhang et al, 2020, Journal of Immunology Research CrossRef
10. Puerarin improves hepatic glucose and lipid homeostasis in vitro and in vivo by regulating the AMPK pathway
    Dong-Xue Xu et al, 2021, Food & Function CrossRef
11. Alisol A Alleviates Arterial Plaque by Activating AMPK/SIRT1 Signaling Pathway in apoE-Deficient Mice
    Ke Wang et al, 2020, Frontiers in Pharmacology CrossRef
12. A Review of the Effects of Puerarin on Glucose and Lipid Metabolism in Metabolic Syndrome: Mechanisms and Opportunities
    Xiaoxuan Jing et al, 2022, Foods CrossRef
13. A Pueraria lobata root extract alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating the gut microbiota and associated metabolites
    Xin Tang et al, 2024, Food Bioscience CrossRef
14. Literature Review on the Use of Herbal Extracts in the Treatment of Non- Alcoholic Fatty Liver Disease
    Yutian Wang et al, 2022, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
15. Puerarin protects endothelial progenitor cells from damage of angiotensin II via activation of ERK1/2‑Nrf2 signaling pathway
    Chen Fu et al, 2017, Molecular Medicine Reports CrossRef
16. Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK/SIRT1 signaling pathway in HepG2 cells
    Jing Zhang et al, 2019, European Journal of Pharmacology CrossRef
17. Structural properties of Kudzu protein enzymatic hydrolysate and its repair effect on HepG2 cells damaged by H2O2 oxidation
    Huina Pang et al, 2023, Food & Function CrossRef
18. Ginkgolide C reduced oleic acid-induced lipid accumulation in HepG2 cells
    Wen-Chung Huang et al, 2018, Saudi Pharmaceutical Journal CrossRef
19. Puerarin attenuates hepatic steatosis via G‐protein‐coupled estrogen receptor‐mediated calcium and SIRT1 signaling pathways
    Thi Hoa Pham et al, 2022, Phytotherapy Research CrossRef
20. Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway
    Lina Gu et al, 2016, Toxicology and Applied Pharmacology CrossRef
21. Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing
    Meng-juan Gong et al, 2021, Journal of Pharmaceutical and Biomedical Analysis CrossRef
22. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease
    Ling-Zu Kong et al, 2019, International Journal of Molecular Sciences CrossRef
23. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease
    Honglin Zhou et al, 2021, European Journal of Pharmacology CrossRef
24. The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products
    Gaoxuan Shao et al, 2022, Frontiers in Pharmacology CrossRef
25. Exploring the protective effect of Modified Xiaochaihu Decoction against hepatic steatosis and inflammation by network pharmacology and validation in ageing rats
    Siting Gao et al, 2020, Chinese Medicine CrossRef
26. Regulation of AMP-activated protein kinase by natural and synthetic activators
    David Grahame Hardie, 2016, Acta Pharmaceutica Sinica B CrossRef
27. A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease
    Wei-Fan Hsu et al, 2016, Evidence-Based Complementary and Alternative Medicine CrossRef
28. The great potential of flavonoids as candidate drugs for NAFLD
    Liangge Li et al, 2023, Biomedicine & Pharmacotherapy CrossRef
29. Tartary Buckwheat Flavonoids Relieve Non-alcoholic Fatty Liver Disease by Inhibiting Lipid Accumulation, Inflammation, and Regulating Intestinal Flora
    Ping Xu et al, 2023, Revista Brasileira de Farmacognosia CrossRef
30. Use of Network Pharmacology to Explore the Mechanism of Gegen (Puerariae lobatae Radix) in the Treatment of Type 2 Diabetes Mellitus Associated with Hyperlipidemia
    Guozhen Yuan et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef